Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly
- PMID: 26023452
- PMCID: PMC4422272
Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly
Abstract
Down's syndrome (DS) is associated with duodenal atresia (DA) in about 8-10% of cases. Transient Myeloproliferative Disorder (TMD)/Acute Myeloid Leukemia (AML) is also associated with the trisomy 21 mutation. The occurrence of the two conditions together complicates the diagnosis and surgical management of the DA. We discuss the technical aspects of management of the DA in this clinical setting.
Keywords: Down's syndrome; Duodenal atresia; Transient myeloproliferative disorder.
References
-
- Choudhry MS, Rahman N, Boyd P, Lakhoo K. Duodenal atresia: associated anomalies, prenatal diagnosis and outcome. Pediatr Surg Int. 2009; 25:727-30. - PubMed
-
- Freeman S, Taft L, Dooley K, Allran K, Sherman SL, Hassold TJ. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet. 1998; 80:213-7. - PubMed
-
- Moiz B, Shafiq M. Transient myeloproliferative disorder. Blood. 2012; 120: 4672. - PubMed
-
- Zipursky A, Brown E, Christensen H, Sutherland R, Doyle J. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Semin Perinatol. 1997; 21:97-101. - PubMed
Publication types
LinkOut - more resources
Full Text Sources